» Articles » PMID: 32407826

Environmental Contamination by SARS-CoV-2 in a Designated Hospital for Coronavirus Disease 2019

Overview
Date 2020 May 15
PMID 32407826
Citations 99
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Coronavirus disease 2019 (COVID-19) is characterized by risk of nosocomial transmission; however, the extent of environmental contamination and its potential contribution of environmental contamination to SARS-CoV-2 transmission are poorly understood. This study aimed to investigate whether environmental contamination may play a role in SARS-CoV-2 transmission.

Methods: Air samples were collected by natural precipitation, and environmental surface samples were collected by conventional surface swabbing. SARS-CoV-2 RNA detection was performed using reverse transcription polymerase chain reaction.

Results: Viral RNA was not detected in the 44 air samples. The positive rates in 200 environmental surface samples in medical areas (24.83%) was higher than that in living quarters (3.64%), with a significant difference (P < .05). The positive rates were 25.00% and 37.50% for the general isolation ward and intensive care unit, respectively, and no significant difference was observed between them (P = .238). The top 5 sampling sites with a positive rate in medical areas were beepers (50.00%), water machine buttons (50.00%), elevator buttons (42.86%), computer mouses (40.00%), and telephones (40.00%).

Conclusions: Most of the touchable surfaces in the designated hospital for COVID-19 were heavily contaminated, suggesting that the environment is a potential medium of disease transmission. These results emphasize the need for strict environmental surface hygiene practices and enhanced hand hygiene to prevent the spread of the virus.

Citing Articles

Combined prevention and treatment measures are essential to control nosocomial infections during the COVID-19 pandemic.

Liu J, Li Y, Wang M, Yang J World J Virol. 2024; 13(2):91286.

PMID: 38984081 PMC: 11229840. DOI: 10.5501/wjv.v13.i2.91286.


A novel strategy for predicting critical illness in hospital-acquired COVID-19.

Cho W Korean J Intern Med. 2024; 39(3):371-372.

PMID: 38715228 PMC: 11076901. DOI: 10.3904/kjim.2024.127.


Risk factors for progressing to critical illness in patients with hospital-acquired COVID-19.

Lee K, Lee J, Lee S, Lee H Korean J Intern Med. 2024; 39(3):477-487.

PMID: 38632896 PMC: 11076898. DOI: 10.3904/kjim.2023.347.


3D-printed shields for slit lamps produced during the COVID-19 pandemic.

Delbarre M, Francois P, Adam J, Caruhel J, Froussart-Maille F, Khonsari R Ann 3D Print Med. 2024; 1:100004.

PMID: 38620717 PMC: 7682428. DOI: 10.1016/j.stlm.2020.100004.


Decay pattern of SARS-CoV-2 RNA surface contamination in real residences.

Lin N, Zhang B, Shi R, Gao Y, Wang Z, Ling Z Sci Rep. 2024; 14(1):6190.

PMID: 38486016 PMC: 10940586. DOI: 10.1038/s41598-024-54445-7.


References
1.
Zuraimi M, Tham K, Chew F, Ooi P . The effect of ventilation strategies of child care centers on indoor air quality and respiratory health of children in Singapore. Indoor Air. 2007; 17(4):317-27. DOI: 10.1111/j.1600-0668.2007.00480.x. View

2.
Riou J, Althaus C . Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Euro Surveill. 2020; 25(4). PMC: 7001239. DOI: 10.2807/1560-7917.ES.2020.25.4.2000058. View

3.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. PMC: 7159299. DOI: 10.1016/S0140-6736(20)30183-5. View

4.
Otter J, Donskey C, Yezli S, Douthwaite S, Goldenberg S, Weber D . Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. J Hosp Infect. 2015; 92(3):235-50. PMC: 7114921. DOI: 10.1016/j.jhin.2015.08.027. View

5.
Ling Y, Xu S, Lin Y, Tian D, Zhu Z, Dai F . Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J (Engl). 2020; 133(9):1039-1043. PMC: 7147278. DOI: 10.1097/CM9.0000000000000774. View